Hostname: page-component-76d6cb85b7-rxvq6 Total loading time: 0 Render date: 2026-07-15T10:17:11.143Z Has data issue: false hasContentIssue false

Stroop performance in multiple sclerosis: Information processing, selective attention, or executive functioning?

Published online by Cambridge University Press:  03 September 2008

J.A.B. MACNIVEN*
Affiliation:
Department of Clinical Psychology and Neuropsychology, Nottingham University Hospitals NHS Trust, and Institute of Work, Health and Organisations, University of Nottingham, Nottingham, United Kingdom
C. DAVIS
Affiliation:
Division of Psychiatry, University of Nottingham, Nottingham, United Kingdom
M.-Y. HO
Affiliation:
Division of Psychiatry, University of Nottingham, Nottingham, United Kingdom
C.M. BRADSHAW
Affiliation:
Division of Psychiatry, University of Nottingham, Nottingham, United Kingdom
E. SZABADI
Affiliation:
Division of Psychiatry, University of Nottingham, Nottingham, United Kingdom
C.S. CONSTANTINESCU
Affiliation:
Division of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom
*
Correspondence and reprint requests to: Jamie Macniven, Department of Clinical Psychology and Neuropsychology, D Floor, West Block, Queen's Medical Centre Campus, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, United Kingdom. E-mail: jamie.macniven@nottingham.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Cognitive impairments in information processing speed, attention and executive functioning are widely reported in patients with multiple sclerosis (MS). Several studies have identified impaired performance on the Stroop test in people with MS, yet uncertainty remains over the cause of this phenomenon. In this study, 25 patients with MS were assessed with a neuropsychological test battery including a computerized Stroop test and a computerized test of information processing speed, the Graded Conditional Discrimination Tasks (GCDT). The patient group was compared with an individually age, sex and estimated premorbid IQ-matched healthy control group. The patients' reaction times (RTs) were significantly longer than those of the controls on all Stroop test trials and there was a significantly enhanced absolute (RTincongruent-RTneutral) and relative (100·[RTincongruent-RTneutral]/RTneutral) Stroop interference effect for the MS group. The linear function relating RT to stimulus complexity in the GCDT was significantly steeper in the patient group, indicating slowed information processing. The results are discussed with reference to the difference engine model, a theory of diversity in speeded cognition. It is concluded that, in the assessment of people with MS, great caution must be used in the interpretation of performance on neuropsychological tests which rely on RT as the primary measure. (JINS, 2008, 14, 805–814.)

Information

Type
Research Article
Copyright
Copyright © The International Neuropsychological Society 2008
Figure 0

Table 1. Demographic data and neuropsychological test scores of the control and patient groups (mean ± SD)

Figure 1

Fig. 1. Relation between RT on the eight tasks of the GCDT and the number of letters in the stimulus array in each task. Ordinate: RT (ms); abscissa: number of letters. Points show group mean data for the MS patient group (open symbols) and matched control group. Lines are best fit linear functions; r2 = 0.99 (patients) and 0.98 (control group).

Figure 2

Table 2. Parameters of linear functions fitted to individual participants' performance on the GCDT (mean ± SD)

Figure 3

Fig. 2. Relation between the patient and control participants groups' RTs on the GCDT and the corresponding RTs of the young “reference group.” Ordinate: RT of the reference group (ms); abscissa: RT of the patient and control groups (ms). Open symbols: control group; filled symbols: patient group. Circles show the RTs on the GCDT; lines are best fit linear functions. Triangles show RTs on the three trial types of the Stroop. Lines are best fit linear functions; r2 = 0.99 for both groups.

Figure 4

Table 3. RTs on the three types of trial of the Stroop test, and the Stroop effect, in the patient and matched control groups (mean ± SD)

Figure 5

Table 4. Discrepancies between obtained RTs on the Stroop test and RTs predicted on the basis of performance on the GCDT (equation 2) (ms, mean ± SD)